Welcome to Gender Analysis

Gender Analysis is a web series launched in 2014 exploring transgender science and life experiences in depth, and revealing the many insights to be found at their intersection. We take a closer look at fields such as sociology, public health, psychiatry, cognitive science, and more, weaving these diverse perspectives into a deeper understanding of gender-related phenomena. Gender Analysis goes beyond the 101s to educate both trans and cis viewers on some of the most fascinating dimensions of our lives – and the pressing issues we face in society.

Support Gender Analysis on Patreon

New episodes of Gender Analysis are published several times a month and are backed by our generous supporters on Patreon. Want to learn more? Check out our instant index for a quick introduction to the wide range of topics we cover:

Curious about…?

Gender dysphoria Self-discovery
How hormones work Bathroom bills
Finding a doctor Treatments for trans youth
Passing Sexuality
Transness and autism Paul McHugh
Regret and detransition Sex chromosomes
Posted in Gender Analysis | Leave a comment

Large study of trans people in the Netherlands shows growing numbers seeking treatment, low regret rates

Medical transition by trans people, its prevalence and demographics, and rates of regret of treatment are perennial subjects of public curiosity and media controversy. With unfortunate frequency, this has taken the form of scaremongering that depicts the growing numbers of trans people presenting for treatment as an almost literal epidemic: the British press now routinely resorts to baseless alarmism and conspiracy theories characterizing the rise in trans youth as resulting from nefarious efforts at “tricking” cis youth into believing they’re trans, a transparent relabeling of the ugly accusations of recruitment leveled at the gay community in decades past. Accompanying such fears are predictions of mass waves of regret to follow, as large numbers of supposedly misdiagnosed individuals come to realize they were cisgender after all.  Continue reading

Posted in Health care, Outcomes of transition, Regret and detransition, Statistics and demographics, Trans youth | Leave a comment

Transgender depersonalization testimonies around the web, 2018

Throughout numerous articles, I’ve covered many aspects of the experience of chronic depersonalization among trans people, a condition of persistent feelings of unreality or having “no self” that’s especially common in untreated gender dysphoria. Symptoms of depersonalization disorder are wide-ranging and can include (Sierra et al., 2005; Fagioli et al., 2015):

  • Disturbances in sense of self: Feeling “robotic”; a sense of seeing oneself from the outside or being an observer of oneself; lacking a sense of ownership over one’s body as if it does not belong to oneself
  • De-affectualization: Emotional numbing; not “truly” feeling emotions when expressing them; a sense of having an empty head or having no thoughts at all, or as if one’s thoughts have a life of their own; not experiencing pleasure or displeasure at the taste or smell of things; detachment from the sense of pain
  • Derealization: Feeling detached from one’s surroundings; seeing the world as colorless, lifeless, or flat; a sense of being unreal
  • Disruptions in sense of time, memory, and perception: Objects appearing smaller or far away; a sense of not being present in one’s own memories of life; feeling that recent events took place long ago

Continue reading

Posted in Awareness building, Depersonalization, Gender dysphoria, Psychology and psychiatry | Leave a comment

Bad trip: What trans people should know about cannabis and depersonalization

Substance abuse is highly prevalent in the transgender population, and is known to be associated with psychosocial risk factors such as stigma, discrimination, and trauma (Glynn & van den Berg, 2017). Notably, trans people use cannabis at an elevated rate compared to the general population. The 2015 US Trans Survey found that 64% of trans people surveyed had ever used cannabis at least once, versus 47% of the population overall, and 25% reported having used cannabis in the past 30 days versus only 8% of the general population (James et al., 2016). Additionally, among those current users, 23% reported using cannabis every day or nearly every day. Continue reading

Posted in Depersonalization, Psychology and psychiatry, Sociological research | Leave a comment

Update on case reports: Cyproterone acetate and meningioma in trans women

Disclaimer: I am not a doctor, and this is not medical advice. Do not take any medication without appropriate medical supervision.

Summary

Cyproterone acetate (CPA) is commonly used as an antiandrogen in HRT for trans women outside of the United States. Use of CPA has been associated with an increased risk of meningioma, a usually-benign brain tumor, in both cis and trans populations, and trans women may face a greater risk due to the high dosage of CPA typically prescribed.

Continue reading

Posted in Endocrinology, Oncology, Transgender medicine | Leave a comment

4thWaveNow “ROGD parent” Brie Jontry doesn’t know what histrelin is

Zinnia Jones4thWaveNow, one of the three survey respondent recruitment sites for the badly flawed study of an alleged new “rapid onset gender dysphoria” condition, has long served as a clearinghouse for questionable notions about puberty-blocking medications used for transgender youth. These include:

  • Scaremongering about the effects of puberty blockers on AMAB genital maturation and the feasibility of vaginoplasty. (Adolescent trans girls on puberty blockers have had successful vaginoplasties since blockers were first used in the early 1990s, and numerous techniques for construction of a vulva and vagina – using whatever amount of tissue is available – have long been used in trans women who transitioned both in adolescence and in adulthood.)
  • Claiming that the use of puberty blockers in gender-dysphoric youth forestalls the physical development that would result in that dysphoria desisting for many of them. (Puberty blockers are already withheld in the earliest stages of puberty so that youth can experience those initial changes, helping to indicate whether their dysphoria will abate or worsen and whether they should discontinue treatment.)
  • Alleging that adolescent gender dysphoria is part of the “normal struggles” of puberty, a crucial developmental task or “identity crisis” in this stage of life that must be allowed to proceed uninterrupted for the sake of reaching their “adult potential”. (Clinical levels of gender dysphoria are extremely uncommon in the general population of adolescents, and there is no evidence that allowing gender dysphoria to remain untreated will result in anything resembling healthier outcomes or improved personal and psychological adjustment.)

Continue reading

Posted in Endocrinology, Health care, Trans youth | Leave a comment